Medicare Part D Gross Spending on GLP-1s Increased Five-Fold Between 2019 and 2024, But Estimated Rebates of Around 50% Mean That Net Spending is Much Lower Gross Medicare Part D spending on GLP-1s in 2024 (not accounting for rebates) totaled $27.5 billion, a five-fold increase from 2019, reflecting an expansion in use of GLP-1s with more recent FDA approvals for type 2 diabetes
QUICKI, quantitative insulin sensitivity check index
Ozempics once-weekly injection provides a consistent benefit and a convenient dosage schedule
Yes, stress produces a compound called a hydrogen peroxide which glutathione neutralizes
GHK-Cu vs other peptides Below is a general comparison between GHK-Cu and other commonly used peptides: Who could the GHK-Cu peptide be suitable for (and who should avoid it)
Zhou J, Feng JY, Wang Q, Shang J